Search results
Gilead's quarterly loss is narrower than expected
Morningstar· 2 hours agoGilead Sciences Inc.'s stock rose 0.8% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected ...
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 9 hours agoSen. Bernie Sanders blasted the Danish drugmaker Novo Nordisk this week for charging U.S. residents...
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Pharmaceutical Technology via Yahoo Finance· 2 hours agoSanders had previously put forth a proposal to cap prices on federally-funded drugs in 2023...of...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 1 day agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks
Quartz· 5 hours agoDrug sales at several pharma companies during the first quarter of the year have exceeded analysts...
Justice Department is investigating McKinsey consulting firm’s role in opioid epidemic – KION546
KION 46 Salinas· 2 hours agoProsecutors from Virginia and Massachusetts are leading the criminal investigation, the sources...
Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
Investor's Business Daily· 1 hour agoHowever, two out of three of Gilead's cancer drugs — cell therapy Tecartus and antibody drug...
US FDA sends warning to Cardinal Health for marketing unapproved devices
WHTC 1450 Holland· 3 hours ago(Reuters) - The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal...
How bird flu virus fragments get into milk sold in stores, and what the spread of H5N1 in cows means...
The Conversation via Yahoo News· 3 hours agoSilva del Rio has received funding from CDFA and USDA-NIFA Richard V. Pereira has received funding...
AI for drug discovery draws a $1 billion launch—and a lot of hope
Fortune via Yahoo Finance· 7 hours agoAny funding round with a B—especially for an early-stage company—represents a big bet and a lot of...